One peptide sold in the research-chemical market has human anxiety trials behind it: Selank, a lab-made version of tuftsin (a short peptide the immune system produces), tested in three Russian studies totalling 192 patients. The first and largest found its anxiety-lowering effect similar to medazepam, a benzodiazepine, alongside psychostimulant effects; the later two compared it against phenazepam and tested it added on top of phenazepam. None was placebo-controlled or designed to prove equivalence. Everything else marketed for anxiety, Semax and BPC-157 included, rests on rat studies or on human data collected for a different condition. None of these compounds is FDA-approved for anxiety in the United States, the trials that exist were published in Russian and have never been repeated by an independent group, and the treatments with large evidence bases remain cognitive behavioural therapy and prescription antidepressants.
Peptides commonly discussed for anxiety
Safety: Nothing here is medical advice, a dosing instruction, or a sourcing guide. Selank, Semax and BPC-157 are not FDA-approved for any use in the United States and are sold as research chemicals without pharmacy oversight; a nasal spray presentation does not indicate review or approval, and an advisory committee recommendation about pharmacy compounding is not an approval and does not cover anxiety. The entire human anxiety evidence base for the peptides sold in this market is 192 patients in three Russian trials that measured neither tolerance nor long-term safety, so absence of reported harm should not be read as a safety record. Anxiety that is new, severe, escalating, or accompanied by panic attacks, chest pain or thoughts of self-harm needs a clinician or emergency service, not a compound adjustment. Never stop a benzodiazepine abruptly to switch to a peptide, because withdrawal can be dangerous and requires a supervised taper, and raise any addition to an SSRI, benzodiazepine or stimulant with the prescriber first, since interaction data does not exist.
Where to buy
Where to get peptides for anxiety
Selank
Buy at Swiss Chems →Semax
Buy at Swiss Chems →Save 10% at checkout with code tcwisiiu
Some links are affiliate links — we may earn a fee at no extra cost to you. Most peptides aren't FDA-approved — consult a qualified clinician and check your local laws before purchasing.
The best human evidence that a peptide can calm anxiety and the best human evidence that a peptide can cause it come from the same 62 patients. Zozulia's 2008 trial found Selank's anxiety-lowering effect similar to medazepam, a benzodiazepine, and recorded psychostimulant effects in the same people 1. That trial is one of three, all Russian, 192 patients in total, and it is the entire human record for this market.
Do peptides for anxiety actually work?
Selank lowered anxiety scores in humans in three trials run by Russian centres between 2008 and 2015 123. No other peptide marketed for anxiety has a human anxiety trial at all, though peptides outside this market have been tested: intranasal oxytocin was studied in social anxiety disorder, where 25 patients randomised to oxytocin or placebo alongside exposure therapy rated their own appearance and speech more positively as sessions progressed but did not finish treatment better off than placebo 8. The table below grades each option by who was studied, in what species, and for which condition, next to the two treatments that carry regulatory approval.
| Option | What it is proposed to do | Human anxiety evidence | US status |
|---|---|---|---|
| Selank | Tuftsin analogue; slows the breakdown of enkephalins, the body's own opioid-like calming peptides, and interacts with GABA signalling 4 | Three Russian trials, 192 patients, each against a benzodiazepine rather than a placebo 123 | Not FDA-approved; sold as research chemical |
| Semax | Fragment of ACTH, the pituitary hormone that drives cortisol release; raises BDNF protein in rat basal forebrain 5 | None. Semax's human trial record is in ischaemic stroke, not anxiety | Not FDA-approved; sold as research chemical. An FDA advisory committee voted in July 2026 to recommend it for the pharmacy compounding list, a non-binding step that did not include anxiety 9 |
| BPC-157 | Gut-brain signalling, studied in rodent anxiety-like behaviour tests | None | Not FDA-approved; sold as research chemical. Also recommended by that same July 2026 advisory vote 9 |
| Collagen peptides | No anxiety-lowering (anxiolytic) mechanism established; glycine, which collagen is rich in, has separate human sleep data that has not been tested for anxiety | None. Gelatin, which is collagen, is used in labs to lower tryptophan, not to calm anxiety 6 | Sold as food supplement |
| SSRIs (sertraline, escitalopram) | Blocks serotonin reuptake in the brain | FDA-approved for generalised anxiety disorder after full clinical development | Prescription medicine |
| Cognitive behavioural therapy | Retrains the response to anxious thoughts | First-line standard of care, no drug involved | Standard clinical care |
Selank: the one peptide with human anxiety trials
The anchor study is Zozulia and colleagues, published in a Russian neurology and psychiatry journal in 2008. Sixty-two patients with generalised anxiety disorder or neurasthenia (an older diagnosis covering persistent mental fatigue with anxiety) were split between Selank, 30 patients, and medazepam, a benzodiazepine, 32 patients. The team scored them on the Hamilton and Zung anxiety scales plus Clinical Global Impression ratings, and measured enkephalin activity in blood 1.
The anxiolytic effects of both drugs were similar but selank had also antiasthenic and psychostimulant effects.Zozulia AA, Neznamov GG, Siuniakov TS, et al., Zh Nevrol Psikhiatr Im S S Korsakova, 2008 [[1]]
Anxiolytic means anxiety-lowering; antiasthenic means it reduced fatigue and low energy; psychostimulant means it lifted drive. All three sat together in the same patients. Those patients had reduced enkephalin activity, meaning their own opioid-like calming peptides were being broken down faster, and the size of that deficit tracked with how long they had been ill and how severe their anxiety was. Enkephalin activity rose during Selank treatment, most clearly in the generalised anxiety disorder group 1. That mechanism, slowing the breakdown of the body's own signalling peptides, works differently from a benzodiazepine, and it is why Vyunova and colleagues describe Selank as interacting with GABA signalling rather than plugging directly into the GABA-A receptor the way a benzodiazepine does 4.
| Trial | Design | Patients | Comparator | What was reported |
|---|---|---|---|---|
| Zozulia 2008 1 | Comparative, anxiety scales plus blood enkephalin activity | 62 (30 Selank, 32 medazepam) | Medazepam, a benzodiazepine | Similar anxiolytic effect to the benzodiazepine, plus reduced fatigue and a stimulant-like effect; enkephalin activity rose |
| Medvedev 2014 2 | Comparative trial in anxiety disorders | 60 | Phenazepam, a benzodiazepine | "Pronounced anxiolytic and mild nootropic effects" (anxiety-lowering plus a mild boost to thinking and memory), with benefit persisting for a week after the last dose |
| Medvedev 2015 3 | Comparative: benzodiazepine alone versus benzodiazepine plus Selank (randomisation not stated) | 70 (30 phenazepam, 40 combination) | Phenazepam monotherapy | The combination reduced benzodiazepine side effects: attention impairment, sedation and sexual disturbance |
What Selank dosage did the trials use?
The published Russian trials do not report their dosing in the abstracts available in English, so anyone quoting a precise "trial dose" for Selank is quoting a forum write-up, since the papers do not give one. The numbers circulating in community write-ups sit at 300 to 900 micrograms a day intranasally for Selank and 200 to 600 micrograms a day for Semax, taken in the morning because of its stimulating edge. Those are reports of what people say they do, listed here so the figures are not mistaken for trial protocol. None of this is a dosing recommendation; whether any of it applies to you is a conversation for a clinician who knows your history and your medications.
| Unverified community reports, not doses | Reported community range | Route | Evidence status |
|---|---|---|---|
| Selank | 300 to 900 mcg/day, most reports at 300 to 600 | Intranasal | No published dose-response curve exists in humans |
| Semax | 200 to 600 mcg/day, mornings | Intranasal | No human anxiety trial exists at any dose |
Semax for anxiety: rat studies and human stroke data
Semax is a modified fragment of ACTH with the hormone-releasing part removed. Dolotov and colleagues showed that Semax binds specifically in rat brain tissue and raises levels of BDNF protein, a growth factor supporting nerve cell survival and plasticity, in the rat basal forebrain 5. Other rat work reports reduced anxiety-like behaviour after early-life drug exposure and antidepressant-like effects under chronic stress; none of it is cited here, because none of it is in humans. The human Semax literature is in ischaemic stroke, from Russian neurology practice, where anxiety was not the endpoint.
Selank or Semax for anxiety
Can peptides cause anxiety?
Yes, peptides can cause anxiety, and the clearest evidence sits inside the peptide anxiety trial itself. Zozulia and colleagues recorded psychostimulant effects alongside the anxiolytic ones 1. A compound that lifts drive and reduces fatigue at the same time as it lowers anxiety scores will not feel calming to everyone, particularly late in the day, and no trial measured what it did to sleep. Semax carries the same profile more strongly, which is why the community convention is morning-only dosing.
A second route runs through cortisol, the stress hormone, and it belongs to the growth hormone peptides, CJC-1295 and ipamorelin among them, rather than to Selank or Semax. The peptides for sleep page covers the trial in full:
Hexarelin, a growth hormone secretagogue (a compound that prods the pituitary into releasing growth hormone), cut stage 4 sleep and whole-night delta power in seven healthy volunteers while pushing up ACTH and cortisol. A compound class sold for deeper sleep made sleep lighter in the one trial that measured the EEG.
Anyone who felt wired rather than rested on a growth hormone peptide has a documented mechanism to point at, and it is not psychosomatic. If that class is what you are actually taking, best peptides for sleep grades each one on the same evidence test used here. The third route is the ordinary one: a new compound, an uncertain dose, an unverified vial, and the expectation of an effect are enough to raise anxiety on their own.
Can collagen peptides cause anxiety?
Collagen peptides have a mechanism worth knowing about, though no human study has tested it as a mood effect, and it has nothing to do with the peptides sold for anxiety. Gelatin is hydrolysed collagen, gelatin contains essentially no tryptophan, and tryptophan is the amino acid the body converts into serotonin. Researchers exploit that on purpose.
How a collagen load can lower serotonin building blocks
Does your DNA predict which anxiety peptide works?
No published study has matched any genotype to Selank or Semax response in a single human being. Genetics can rank which hypotheses are worth testing first. Four variants come up, and here is where each one stands.
- COMT rs4680 (Val158Met) influences how fast the prefrontal cortex clears dopamine, alongside other factors. Fast clearers and slow clearers plausibly tolerate a stimulating compound differently, which is the mechanistic argument people make for Semax. It has never been tested against Semax or Selank response.
- BDNF rs6265 (Val66Met) changes activity-dependent release of BDNF, the growth factor Semax raises in rat brain 5. The link from genotype to a human anxiety outcome on Semax is unstudied.
- SLC6A4 5-HTTLPR, the serotonin transporter promoter variant popular writing leans on, is a roughly 43 to 44 base-pair insertion or deletion rather than a single-letter change. Consumer genotyping chips cannot read it directly; services that report it are inferring it from nearby proxy SNPs, which is not the same variant.
- FKBP5 rs1360780 sits in cortisol regulation and appears in stress-reactivity association work. No peptide-response data exists for it.
No product can tell you whether Selank will work for you, and any claim otherwise is selling ahead of the evidence.
Cost, storage, and how long the studies ran
Research-chemical pricing sits well below prescription anxiety care, which is part of the appeal and part of the risk. On the vendor prices we track for our vendor comparison, Selank runs about $26 a vial and Semax about $74, both as lyophilised (freeze-dried) powder, which is a raw material and not a finished medicine. PeptidesDNA earns a commission if you buy through links on that comparison page, which is why the prices are published rather than the vendors ranked by anything else.
- Storage: freeze-dried peptide powder is stable in a fridge or freezer while sealed and dry. Once mixed with bacteriostatic water it goes in the fridge and is treated as a short-lived preparation, typically discussed in weeks rather than months.
- Verification: no research-chemical vendor is subject to pharmacy oversight. A third-party certificate of analysis with mass spectrometry identity is the minimum a buyer can ask for, and it still does not make an unapproved drug an approved one.
- Time to effect in the literature: the Selank trials measured change on anxiety scales over weeks of treatment, not after a single dose, and the Medvedev 2014 benefit was reported as persisting about a week after the last dose 2.
- What no study has established: tolerance, dependence risk, long-term safety, effects in pregnancy or breastfeeding, and interactions with SSRIs or benzodiazepines. Each of those is simply unknown.
No genotype predicts response to Selank or Semax. Upload your raw DNA data and the report shows which hypotheses your own COMT, BDNF and stress-pathway variants put first, which of the 39 peptides have no genetic story at all, and the evidence tier for each one stated plainly.
Get your DNA report- Among the peptides sold for anxiety, only Selank has human anxiety trials
Selank was tested in 192 patients across three trials published in Russian between 2008 and 2015, each against a benzodiazepine rather than a placebo. Semax, BPC-157 and every other compound on a "best peptides for anxiety" list has no human anxiety trial at all. Peptides outside this market have been trialled in anxiety, for instance intranasal oxytocin in social anxiety disorder, where 25 patients improved their self-evaluation during exposure sessions without improving overall treatment outcome. Any ranking that presents the research-chemical peptides as tiers of the same evidence is marketing.
- The clearest peptide-causes-anxiety evidence is in the peptide anxiety trial itself
Zozulia and colleagues reported psychostimulant effects, meaning lifted drive and reduced fatigue, alongside Selank's anxiolytic effects in the same 62-patient study. A compound that does both will not read as calming to everyone, and no trial measured what it did to sleep.
- Collagen is the one peptide product with a plausible mechanism for worse mood, tested only in rats
Gelatin is hydrolysed collagen, gelatin carries essentially no tryptophan, and gelatin-based mixtures are the standard laboratory method for acute tryptophan depletion in animal work. No human study has tested collagen supplements as a mood effect. Taken alongside complete protein this is a non-issue; taken in place of it, the direction of travel is the one researchers use deliberately.
Frequently asked questions
Can peptides cause anxiety?
Yes, by three documented routes. The 62-patient Selank trial reported psychostimulant effects alongside the anxiety reduction, so the best-evidenced anxiety peptide also has a stimulating component that will not suit everyone, especially late in the day [[1]]. Separately, hexarelin, a growth hormone secretagogue, raised ACTH and cortisol and cut deep sleep in seven healthy volunteers, which gives anyone who felt wired on that class a real mechanism to point at [[7]]. Collagen peptides run through a third route entirely: gelatin, which is collagen, is the standard laboratory vehicle for lowering tryptophan, the building block of serotonin, though that work is in rats and no human study has tested collagen as a mood effect [[6]].
What is the Selank dosage for anxiety?
No published Selank trial reports its dosing in an English-language abstract, so any specific "clinical dose" quoted online comes from community write-ups rather than from the papers. Those write-ups cluster at 300 to 900 micrograms a day intranasally, most reports at 300 to 600. There is no published human dose-response curve for Selank, no trial-derived cycling rule, and no approved product carrying a label. Dosing belongs with a clinician who knows your history and your medications, and there is no interaction data for Selank with SSRIs, benzodiazepines or stimulants.
Is Selank nasal spray legal in the US, and is it FDA-approved?
Selank is not FDA-approved for any indication in the United States and cannot be compounded by a US pharmacy under FDA sanction. It is sold as a research chemical, and a nasal spray presentation does not change that. The regulatory picture has moved, and the two compounds on this page took different paths. Selank acetate was removed from FDA's interim Category 2 list in September 2024 after the nominator withdrew the nomination; withdrawal stops FDA evaluation and is not a safety clearance. Semax went the other way: FDA removed it from Category 2 in 2026 and referred it to the Pharmacy Compounding Advisory Committee, which voted 8 to 5 on 24 July 2026 to recommend adding it to the 503A bulk substances list for cerebral ischaemia, migraine and trigeminal neuralgia [[9]]. That vote is advisory, FDA has not made a final decision, rulemaking of this kind typically takes a year or more, and no listed indication is anxiety. Status as of August 2026: possession is not criminalised, marketing either compound as a treatment is not lawful, and neither is available as an FDA-sanctioned compounded medicine.
Semax vs Selank: which is better for anxiety?
Selank is the one with human anxiety trials: three of them, 192 patients, with the first finding its anxiolytic effect similar to medazepam and the later two testing it against and then alongside phenazepam [[1]][[2]][[3]]. None was placebo-controlled or designed to prove equivalence. Semax has no human anxiety trial at all. Its anxiety-relevant results are in rats, and its human record is in ischaemic stroke, from Russian neurology practice. That is also roughly the indication set an FDA advisory committee considered in July 2026 when it voted to recommend Semax for pharmacy compounding, and none of those indications is anxiety, so even a final approval there would not make Semax an approved anxiety treatment [[9]]. People choose Semax for the anxiety-plus-mental-fatigue pattern on mechanism reasoning rather than on trial evidence, and its stimulating profile is the reason some users report feeling more anxious rather than less.
Do peptides help with ADHD and anxiety together?
No peptide has been tested for ADHD in a controlled human trial, and the stacks aimed at depression, ADHD and anxiety together have no human peptide evidence behind them. Talk to the clinician managing your care before adding anything to a prescribed regimen.
Sources9
- Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
- Medvedev VE, Tereshchenko ON, Israelian AIu, et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22.
- Medvedev VE, Tereshchenko ON, Kost NV, et al. Optimization of the treatment of anxiety disorders with selank. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):33-40.
- Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF. Peptide-based anxiolytics: the molecular aspects of heptapeptide selank biological activity. Protein Pept Lett. 2018;25(10):914-923.
- Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA, Kamensky AA, Grivennikov IA, Engele J, Myasoedov NF. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006;97 Suppl 1:82-6.
- Jans LAW, Lieben CKJ, Blokland A. Influence of sex and estrous cycle on the effects of acute tryptophan depletion induced by a gelatin-based mixture in adult Wistar rats. Neuroscience. 2007;147(2):304-17.
- Frieboes RM, Antonijevic IA, Held K, Murck H, Pollmacher T, Uhr M, Steiger A. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Psychoneuroendocrinology. 2004;29(7):851-60.
- Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 2009;34(6):917-23.
- US Food and Drug Administration. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. Committee voted 8-5 to recommend Semax for the 503A bulk drug substances list for cerebral ischemia, migraine and trigeminal neuralgia; recommendation is non-binding.
This article is for informational and educational purposes only. It is not medical advice and does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any peptide protocol. Individual results vary. Some outbound links are affiliate links, at no extra cost to you.
This page is educational and is not medical advice. Peptides are not intended to diagnose, treat, cure, or prevent any disease, and most are not FDA-approved. Talk to a qualified healthcare provider before starting anything. Availability and legal status of peptides vary by jurisdiction.
← All condition guides